195 results
Page 2 of 10
6-K
EX-99.1
3rsvg
18 Oct 23
Current report (foreign)
6:20am
6-K
uxdiwh2psgzwf
2 Oct 23
Current report (foreign)
6:17am
6-K
62pb84w1d amxszek
28 Sep 23
Current report (foreign)
6:17am
6-K
k4urr4
11 Sep 23
Current report (foreign)
6:50am
6-K
6r9byt8ue o0ur0gif
1 Aug 23
Current report (foreign)
6:10am
6-K
EX-99.1
19koyf1sv g2is1
27 Jul 23
Current report (foreign)
6:05am
6-K
EX-99.1
btbwj4memdw2hqc9b4rt
12 Jul 23
Current report (foreign)
6:07am
6-K
EX-99.1
i6khxa7
6 Jul 23
Current report (foreign)
6:18am
6-K
etv35s03t
28 Jun 23
Current report (foreign)
6:02am
6-K
EX-99.1
j9z 2a768vc6
23 Jun 23
Current report (foreign)
6:13am
6-K
ok6h zebp
30 May 23
Current report (foreign)
6:20am
6-K
EX-99.1
olblwetu 4xwil7k90rj
30 May 23
Current report (foreign)
6:19am
6-K
EX-99.1
thv4bb
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
0zxnrky39886n
30 May 23
Current report (foreign)
6:11am
6-K
ot261twoxiqhadfvfdo
17 May 23
Current report (foreign)
6:02am
6-K
t8lntszgz
11 May 23
Current report (foreign)
6:10am
6-K
y05d5lt
11 May 23
Current report (foreign)
6:07am
6-K
EX-99.1
t07cwhz
11 May 23
Current report (foreign)
6:07am
6-K
EX-99.1
543zux98plksq
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am